Drug
Tedisamil sesquifumarate clinical trials
How studies write it
Studies that test it under each name
By phase
A phase 1/2 study counts in both.
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses tedisamil sesquifumarate is read from its arms, and is right about nine times in ten.
Testing it · 3
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedPhase 3Solvay PharmaceuticalsNCT00126074Written as Tedisamil sesquifumarate
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedPhase 3Solvay PharmaceuticalsNCT00126022Written as Tedisamil sesquifumarate
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male SubjectsCompletedPhase 3Solvay PharmaceuticalsNCT00126061Written as Tedisamil sesquifumarate
Codes
What other systems call tedisamil sesquifumarate · ClinicalTrials.gg INT018545
- UNII (FDA) Y4HRG433UUTEDISAMIL SESQUIFUMARATEConfirmed FDA, Wikidata
- Wikidata Q27294255tedisamil sesquifumarateConfirmed FDA, Wikidata
- NCI Thesaurus C73802Tedisamil SesquifumarateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Y4HRG433UU | TEDISAMIL SESQUIFUMARATE | Confirmed FDA, Wikidata |
| Wikidata | Q27294255 | tedisamil sesquifumarate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C73802 | Tedisamil Sesquifumarate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.